SLU-PP-332 5mg For Sale
What is SLU-PP-332?
SLU-PP-332 is a small-molecule research compound that functions as a pan-agonist of the three estrogen-related receptors (ERR-alpha, ERR-beta, and ERR-gamma). With a molecular formula of C20H22N2O3 and a molecular weight of approximately 338.4 g/mol, it was first reported in published metabolic research literature by Saint Louis University in 2023. SLU-PP-332 is studied in research models that investigate ERR pathway signaling, mitochondrial biogenesis, oxidative metabolism, and exercise-mimetic transcriptional pathways. Supplied in two formats — a 5mg lyophilized powder vial and 250mcg oral tablets (100 count) — it is also referenced as SLU PP 332, SLUPP-332, or pan-ERR agonist. Triumphant Labs SLU-PP-332 is provided strictly for in vitro research applications and is not approved for human or animal use.
SLU-PP-332 Structure
Molecular Formula
Molecular Weight
290.3 g/mol
PubChem SID
5338394
CAS Number
303760-60-3
Synonyms
4-Hydroxy-N’-(naphthalen-2-ylmethylene) benzohydrazide
DISCLAIMER: By purchasing from Triumphant Labs you agree that you are purchasing Research Chemicals which are in no way intended for use in humans.
Triumphant Labs products are furnished for LABORATORY RESEARCH USE ONLY. This product should only be handled by qualified, and licensed professionals. The product may not be used as a drug, agricultural or pesticidal product, food additive or household chemical – and may not be misbranded as such. Bodily introduction of any kind into humans and/or animals is strictly forbidden by law.
Research Chemicals ARE NOT DIETARY SUPPLEMENTS OR PRESCRIPTION MEDICATIONS THEY ARE *RESEARCH CHEMICALS.
*Research chemicals are chemical substances used by scientists for medical and scientific research purposes. One characteristic of a research chemical is that it is for laboratory research use only; a research chemical is not intended for human or veterinary use. This distinction is required on the labels of research chemicals, and is what exempts them from regulation under parts 100-740 in Title 21 of the Code of Federal Regulations (21CFR).















Reviews
There are no reviews yet.